COVID-19: riesgos de la medicación sin evidencia / COVID-19: medication risks without evidence

Javier Lovo

Texto completo:

PDF

Resumen

Introducción: la aparición de crisis sanitarias globales, como la
ocasionada por el virus SARS Cov-2, generan profundos dilemas
éticos. La población exige medidas de atención y profilaxis con
rapidez. Propiciando que muchas personas, incluso profesionales
de la salud, oferten medicamentos sin ningún tipo de evidencia.

Objetivo: argumentar la necesidad de la evidencia, en los
medicamentos que se ofertan para el manejo y prevención de la
COVID-19.

Desarrollo: la medicina basada en la evidencia aparece, como
tal, después de los 1900. Antes de esta fecha, la medicina estaba
basada en la creencia y la experiencia. Con el surgimiento de la
crisis sanitaria actual, la población exige medicamentos para la
curación de la enfermedad. Esto permite que aparezcan personas,
ofertando tratamientos sin fundamento y promoviendo fármacos
para profilaxis sin base científica.

Conclusiones: no existe ningún fármaco aprobado
específicamente para el tratamiento o profilaxis de la COVID-19.
Toda intervención debe basarse en los sanos principios de la
medicina, fundamentándose en la mejor evidencia disponible.

Palabras clave: bioética; discusiones bioéticas; derechos del
paciente; infecciones por coronavirus.

ABSTRACT

Introduction: the appearance of global health crises, such
as that generated by the SARS Cov-2 virus, generate profound
ethical dilemmas. The population demands measures of attention
and prophylaxis quickly. Encouraging that many people, including
health professionals, offer medications without any evidence.

Objective: to argue the need for evidence, in the medications
offered for the management and prevention of COVID-19.

Development: Evidence-based medicine appears as such after
the 1900s. Before this date, medicine was based on belief and experience. With the emergence of the current health crisis, the population is demanding medications to cure the disease. This allows people to appear, offering unproved treatments and promoting no evidence prophylaxis drugs.

Conclusions: there is no drug specifically approved for the
treatment or prophylaxis of COVID-19. All interventions must
be established on the principles of medicine based on the best
available evidence.

Keywords: Bioethics; Bioethical Issues; Patient Rights;
Coronavirus Infections.

Palabras clave

Bioética; Discusiones Bioéticas; Derechos del Paciente; Infecciones por Coronavirus

Referencias

Ahn DG, Shin HJ, Kim MH et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol [Internet]. 2020;30(3):313-24. [citado 01/06/2020]. Disponible en: https://doi.org/10.4014/jmb.2003.03011

Contini C, Di Nuzzo M, Barp N et al. The novel zoonotic COVID-19 pandemic: An expected global health concern. J Infect Dev Ctries [Internet]. 2020;14(3):254-64. [citado 01/06/2020]. Disponible en: https://doi.org/10.3855/jidc.12671

Giubilini A, Douglas T, Maslen H, Savulescu J. Quarantine, isolation and the duty of easy rescue in public health. Dev World Bioeth[Internet]. 2018;18(2):182-89. [citado 01/06/2020]. Disponible en: https://doi.org/10.1111/dewb.12165

Bryant KB. We Can't Just Wash Our Hands: a Primary Care Physician's Thoughts on COVID-19 and Her Community [published online ahead of print, 2020 Apr 20]. J Gen Intern Med [Internet]. 2020;1-2. [citado 01/06/2020]. Disponible en: https://doi.org/10.1007/s11606-020-05831-0

Erku DA, Belachew SA, Abrha S, et al. When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19 [published online ahead of print, 2020 May 1]. Res Social Adm Pharm [Internet]. 2020;S1551 (20). [citado 02/06/2020]. Disponible en: https://doi.org/10.1016/j.sapharm.2020.04.032

Sesagiri Raamkumar A, Tan SG, Wee HL. Measuring the Outreach Efforts of Public Health Authorities and the Public Response on Facebook During the COVID-19 Pandemic in Early 2020: Cross-Country Comparison. J Med Internet Res[Internet]. 2020;22(5):e19334. [citado 02/06/2020]. Disponible en: https://doi.org/10.2196/19334

Tonelli MR. Evidence-free medicine: forgoing evidence in clinical decision making. Perspect Biol Med [Internet]. 2009;52(2):319-31. [citado 02/06/2020]. Disponible en: https://doi.org/10.1353/pbm.0.0087

Black D. Evidence-free medicine. Clin Med (Lond) [Internet]. 2002;2(5):474-75. [citado 02/06/2020]. Disponible en: https://doi.org/10.7861/clinmedicine.2-5-474

Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ[Internet]. 1996; 312(7023), 71–2. [citado 02/06/2020]. Disponible en: https://doi.org/10.1136/bmj.312.7023.71

Tonelli MR, Shapiro D. Experiential knowledge in clinical medicine: use and justification [published online ahead of print, 2020 Apr 24]. Theor Med Bioeth [Internet] . 2020. [citado 03/06/2020]. Disponible en: https://doi.org/10.1007/s11017-020-09521-0

Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on. Lancet[Internet]. 2017;390(10092):415-23. [citado 03/06/2020]. Disponible en: https://doi.org/10.1016/S0140-6736(16)31592-6

Tonelli MR. The challenge of evidence in clinical medicine. J Eval Clin Prac[Internet] . 2010; 16(2), 384-89. [citado 04/06/2020]. Disponible en: https://doi.org/10.1111/j.1365-2753.2010.01405.x

Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan, B et al. COVID-19: A promising cure for the global panic. Sci Total Environ [Internet]. 2020;725. [citado 04/06/2020]. Disponible en: https://doi.org/10.1016/j.scitotenv.2020.138277

Broche Candó JM, Broche Candó RC, García Hernández LY, Cañedo Andalia R. Medicina basada en la evidencia: un reto para el médico contemporáneo. ACIMED [Internet]. 2003 ; 11( 6 ). [citado 04/06/2020]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1024-94352003000600003&lng=es.

Manzini JL. declaración de helsinki: principios éticos para la investigación médica sobre sujetos humanos. Acta bioeth [Internet]. 2000 ; 6( 2 ): 321-34. [citado 05/06/2020]. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S1726-569X2000000200010&lng=es

Krouse HJ. Whatever Happened to Evidence-Based Practice During COVID-19? [published online ahead of print, 2020 May 19]. Otolaryngol Head Neck Surg[Internet]. 2020. [citado 05/06/2020]. Disponible en: https://doi.org/10.1177/0194599820930239

Wu J, Zha P. Flaws In Medicine Must Be Corrected: An Open Report to National Governments amid the Pandemic [e-book].1er ed. Healthtier World[Internet]. 2020. [citado 07/06/2020]. Disponible en: https://doi.org/10.31219/osf.io/6wy9j

Lenzer J, Brownlee s. Pandemic Science Out of Control. Issues in Science and Technology [Internet]. 2020, abril 28. [citado 07/06/2020]. Disponible en: https://issues.org/pandemic-science-out-of-control/

Smith CM. Origin and uses of primum non nocere--above all, do no harm!. J Clin Pharmacol [Internet]. 2005;45(4):371-77. [citado 07/06/2020]. Disponible en: https://doi.org/10.1177/0091270004273680

Centers for Disease Control and Prevention. Information for clinicians on investigational therapeutics for patients with COVID-19. [citado 08/06/2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html

Oliva Marín J. Posibles estrategias de tratamiento para COVID-19. [published online ahead of print]. Alerta [Internet]. 6may 2020 ;3(2). [citado 08/06/2020]. Disponible en: https://doi.org/10.5377/alerta.v3i2.9626

Soto A. Cuando la vehemencia supera la evidencia: el caso del uso de hidroxicloroquina para el tratamiento del COVID-19. Acta méd. Peru [Internet]. 2020 ; 37( 1 ): 110-11. [citado 09/05/2020]. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1728-59172020000100110&lng=es. http://dx.doi.org/10.35663/amp.2020.371.914

Agrawal S, Goel AD, Gupta N. Emerging prophylaxis strategies against COVID-19. Monaldi Arch Chest Dis [Internet].2020; 90(1):169-72. [citado 09/06/2020]. Disponible en: http://dx.doi.org/10.4081/monaldi.2020.1289

Chary MA, Barbuto AF, Izadmehr S, Hayes BD, Burns MM. COVID-19: Therapeutics and Their Toxicities [published online ahead of print, 2020 Apr 30]. J Med Toxicol[Internet] . 2020;1-11. [citado 10/06/2020]. Disponible en: http://dx.doi.org/10.1007/s13181-020-00777-5

Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review [published online ahead of print, 2020 Apr 29]. J Intern Med [Internet]. 2020; 00: 1-15. . [citado 11/06/2020]. Disponible en: http://dx.doi.org/10.1111/joim.13091

Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2020 Panorama. Cuba y Salud

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.